Risk factor
Strong trading liquidity
Profitability factor
Favourable analyst view
About
Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Additionally, the company diversifies its activities into property development, real estate management, and leasing services. Founded in Changchun, China, in 1993, this enterprise was previously known as Changchun High & New Technology Industry (Group) Inc.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD
Target Price
The average target price of 000661.SZ is 103 and suggests 42.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to